These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22023894)
41. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause: executive summary of recommendations. Goodman NF; Cobin RH; Ginzburg SB; Katz IA; Woode DE; Endocr Pract; 2011; 17(6):949-54. PubMed ID: 22193145 [No Abstract] [Full Text] [Related]
42. Comments about the severe fracture concept used in the 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, by Briot et al. Pouilles JM Joint Bone Spine; 2012 Oct; 79(5):527-8; author reply 528-9. PubMed ID: 23041470 [No Abstract] [Full Text] [Related]
43. How do women develop fragile bones? Reeve J J Steroid Biochem Mol Biol; 2000 Nov; 74(5):375-81. PubMed ID: 11162947 [No Abstract] [Full Text] [Related]
44. Not all SERMs are created equal: chapter 2. Goldstein SR Menopause; 2015 Aug; 22(8):802-3. PubMed ID: 26102533 [No Abstract] [Full Text] [Related]
52. [Effect of tamoxifen on the bone mass]. Lima FA; Szejnfeld VL; Baracat EC; Atra E; Lima GR Rev Assoc Med Bras (1992); 1992; 38(4):231-3. PubMed ID: 1340384 [No Abstract] [Full Text] [Related]
53. Concerns on modeling postmenopausal osteoporosis on young female rats. Lelovas P; Dontas I J Orthop Surg Res; 2019 Dec; 14(1):450. PubMed ID: 31852495 [No Abstract] [Full Text] [Related]
54. Response to Letter to the Editor: Concerns on modeling postmenopausal osteoporosis in young female rats. Rocabado JMR; Kaku M; Nozaki K; Ida T; Kitami M; Aoyagi Y; Uoshima K J Orthop Surg Res; 2019 Dec; 14(1):451. PubMed ID: 31852490 [No Abstract] [Full Text] [Related]
55. Effect on bone of withdrawal of oestrogen therapy. Aitken JM Lancet; 1979 Jul; 2(8135):195-6. PubMed ID: 89300 [No Abstract] [Full Text] [Related]
56. Oral surgery: The drug holiday. Shiels D; Goodall A Br Dent J; 2017 Oct; 223(7):464. PubMed ID: 29026231 [No Abstract] [Full Text] [Related]
57. Bones of contention. Pini P Lancet; 1993 Apr; 341(8850):950-1. PubMed ID: 8096280 [No Abstract] [Full Text] [Related]
58. Editorial overview: Musculoskeletal: Where are we with treating musculoskeletal disorders? Orriss IR; MacRae VE Curr Opin Pharmacol; 2016 Jun; 28():iv-vi. PubMed ID: 27067741 [No Abstract] [Full Text] [Related]
59. Characterisation of Bone Beneficial Components from Australian Wallaby Bone. Lao W; Jin X; Tan Y; Xiao L; Padula MP; Bishop DP; Reedy B; Ong M; Kamal MA; Qu X Medicines (Basel); 2016 Aug; 3(3):. PubMed ID: 28930133 [No Abstract] [Full Text] [Related]
60. Duration of treatment in postmenopausal osteoporosis: how long to treat and what are the consequences of cessation of treatment? Laster AJ; Tanner SB Rheum Dis Clin North Am; 2011 Aug; 37(3):323-36, v. PubMed ID: 22023894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]